Evidence map›Paper›PMID 29365319›Full record

ArticleBlood advances2018

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications.

E Dianne Pulte, Lei Nie, Nicole Gormley, Kirsten B Goldberg, Amy McKee, Ann Farrell, Richard Pazdur

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

E Dianne PulteCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.ORCID 0000-0003-3233-6206
Lei NieCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Nicole GormleyCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Kirsten B GoldbergCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.ORCID 0000-0001-8659-1240
Amy McKeeCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.ORCID 0000-0002-9268-5574
Ann FarrellCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.ORCID 0000-0001-8477-3972
Richard PazdurCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.ORCID 0000-0002-4771-9923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overClinical Trials as TopicEthnicityFemaleHumansImmunologic FactorsImmunomodulationMaleMiddle AgedMinority GroupsMultiple MyelomaProteasome InhibitorsImmunologic FactorsProteasome Inhibitors

Identifiers

PMID29365319
PMCPMC5786427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.